Effect of Gene-Mercury Interactions on Mercury Toxicokinetics and Neurotoxicity

Current environmental health reports

Volumn 2, Issue 2, 2015, Pages 179-194

  Llop, Sabrina ^a,b,c,d   Ballester, Ferran ^a,b,d   Broberg, Karin ^c  

^a UNIVERSITY OF VALENCIA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c KAROLINSKA INSTITUTE   (Sweden)

^d Foundation for the Promotion of Health and Biomedical Research in the Valencian Region   (Spain)

Author keywords

ABCC2; APOE; BDNF; Cognitive; GCLM; Glutathione

Indexed keywords

MERCURY;

GENETIC POLYMORPHISM; GENETICS; HUMAN; TOXICITY AND INTOXICATION; TOXICOKINETICS;

HUMANS; MERCURY; NEUROTOXICITY SYNDROMES; POLYMORPHISM, GENETIC; TOXICOKINETICS;

EID: 84955738899     PISSN: None     EISSN: 21965412     Source Type: Journal    
DOI: 10.1007/s40572-015-0047-y     Document Type: Article

References (53)

1. Driscoll CT, Mason RP, Chan HM, et al. Mercury as a global pollutant: sources, pathways, and effects. Environ Sci Technol. 2013;47(10):4967–83.
2. World Health Organization (WHO). Children's exposure to mercury compounds. 2010. http://www.who.int/phe/news/Mercury-flyer.pdf.
3. Parks JM, Johs A, Podar M, et al. The genetic basis for bacterial mercury methylation. Science. 2013;339(6125):1332–5.
4. Institute of Medicine (IOM). Seafood Choices, Balancing Benefits and Risks. Committee on Nutrient Relationships in Seafood: Selections to Balance Benefits and Risks. Washington, D.C: The National Academies Press; 2006.
5. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA. 2006;296(15):1885–99.
6. Clarkson TW, Magos L. The toxicology of mercury and its chemical compounds. Crit Rev Toxicol. 2006;36(8):609–62.
7. Bose-O'Reilly S, Drasch G, Beinhoff C, et al. Health assessment of artisanal gold miners in Indonesia. Sci Total Environ. 2010;408(4):713–25.
8. Frumkin H, Letz R, Williams PL, et al. Health effects of long-term mercury exposure among chloralkali plant workers. Am J Ind Med. 2001;39(1):1–18.
9. Anglen J, Stayner L, Gruninger S. 0414 Cumulative mercury exposure and peripheral nerve function in a sample of U.S. dental professionals. Occup Environ Med. 2014;71 Suppl 1:A116.
10. Rice D, Barone Jr S. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect. 2000;108 Suppl 3:511–33.
11. Grandjean P, Landrigan PJ. Neurobehavioural effects of developmental toxicity. Lancet Neurol. 2014;13(3):330–8.
12. Selevan SG, Kimmel CA, Mendola P. Identifying critical windows of exposure for children's health. Environ Health Perspect. 2000;108 Suppl 3:451–5.
13. Davidson P, Myers G, Cox C, et al. Effects of prenatal and postnatal methylmercury exposure from fish consumption on neurodevelopment. JAMA. 1998;280(8):701–7.
14. Grandjean P, Weihe P, White RF, et al. Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol. 1997;19(6):417–28.
15. Karagas MR, Choi AL, Oken E, et al. Evidence on the human health effects of low-level methylmercury exposure. Environ Health Perspect. 2012;120(6):799–806.
16. Llop S, Guxens M, Murcia M, et al. Prenatal Exposure to Mercury and Infant Neurodevelopment in a Multicenter Cohort in Spain: Study of Potential Modifiers. Am J Epidemiol. 2012;175(5):451–65.
17. Castoldi AF, Johansson C, Onishchenko N, et al. Human developmental neurotoxicity of methylmercury: impact of variables and risk modifiers. Regul Toxicol Pharmacol. 2008;51(2):201–14.
18. Gundacker C, Gencik M, Hengstschlager M. The relevance of the individual genetic background for the toxicokinetics of two significant neurodevelopmental toxicants: mercury and lead. Mutat Res. 2010;705(2):130–40.
19. National Research Council. Scientific frontiers in developmental toxicology and risk assessment. 2nd ed; 2000
20. Harris SE, Fox H, Wright AF, et al. A genetic association analysis of cognitive ability and cognitive ageing using 325 markers for 109 genes associated with oxidative stress or cognition. BMC Genet. 2007;8:43.
21. Ropers HH. Genetics of early onset cognitive impairment. Annu Rev Genomics Hum Genet. 2010;11:161–87.
22. Ballatori N. Transport of toxic metals by molecular mimicry. Environ Health Perspect. 2002;110 Suppl 5:689–94.
23. Mason HJ, Hindell P, Williams NR. Biological monitoring and exposure to mercury. Occup Med (Lond). 2001;51(1):2–11.
24. Clarkson TW, Vyas JB, Ballatori N. Mechanisms of mercury disposition in the body. Am J Ind Med. 2007;50(10):757–64.
25. Llop S, Engstrom K, Ballester F, et al. Polymorphisms in ABC transporter genes and concentrations of mercury in newborns—evidence from two Mediterranean birth cohorts. PLoS One. 2014;9(5):e97172. This study provides evidence of the influence of ABC transporters polymorphisms on mercury transfer across the placenta in three Mediterranean birth cohorts.
26. Miura K, Clarkson TW. Reduced methylmercury accumulation in a methylmercury-resistant rat pheochromocytoma PC12 cell line. Toxicol Appl Pharmacol. 1993;118(1):39–45.
27. Toyama T, Shinkai Y, Yasutake A, et al. Isothiocyanates reduce mercury accumulation via an Nrf2-dependent mechanism during exposure of mice to methylmercury. Environ Health Perspect. 2011;119(8):1117–22.
28. Lee BE, Hong YC, Park H, et al. Interaction between GSTM1/GSTT1 polymorphism and blood mercury on birth weight. Environ Health Perspect. 2010;118(3):437–43.
29. Gundacker C, Komarnicki G, Jagiello P, et al. Glutathione-S-transferase polymorphism, metallothionein expression, and mercury levels among students in Austria. Sci Total Environ. 2007;385(1–3):37–47.
30. Gundacker C, Wittmann KJ, Kukuckova M, et al. Genetic background of lead and mercury metabolism in a group of medical students in Austria. Environ Res. 2009;109(6):786–96.
31. Bourdineaud JP, Laclau M, Maury-Brachet R, et al. Effects of Methylmercury Contained in a Diet Mimicking the Wayana Amerindians Contamination through Fish Consumption: Mercury Accumulation, Metallothionein Induction, Gene Expression Variations, and Role of the Chemokine CCL2. Int J Mol Sci. 2012;13(6):7710–38.
32. Engstrom K, Stromberg U, Lundh T, et al. Genetic variation in glutathione-related genes and body burden of methylmercury. Environ Health Perspect. 2008;116(6):734–9.
33. Engstrom KS, Wennberg M, Stromberg U, et al. Evaluation of the impact of genetic polymorphisms in glutathione-related genes on the association between methylmercury or n-3 polyunsaturated long chain fatty acids and risk of myocardial infarction: a case–control study. Environ Health. 2011;10:33.
34. Custodio HM, Broberg K, Wennberg M, et al. Polymorphisms in glutathione-related genes affect methylmercury retention. Arch Environ Health. 2004;59(11):588–95.
35. Custodio HM, Harari R, Gerhardsson L, et al. Genetic influences on the retention of inorganic mercury. Arch Environ Occup Health. 2005;60(1):17–23.
36. Engstrom K, Ameer S, Bernaudat L, et al. Polymorphisms in genes encoding potential mercury transporters and urine mercury concentrations in populations exposed to mercury vapor from gold mining. Environ Health Perspect. 2013;121(1):85–91. This study reports the influence of certain polymorphism on inorganic mercury exposure among occupationally exposed population.
37. Goodrich JM, Wang Y, Gillespie B, et al. Glutathione enzyme and selenoprotein polymorphisms associate with mercury biomarker levels in Michigan dental professionals. Toxicol Appl Pharmacol. 2011;257(2):301–8.
38. Harari R, Harari F, Gerhardsson L, et al. Exposure and toxic effects of elemental mercury in gold-mining activities in Ecuador. Toxicol Lett. 2012;213(1):75–82.
39. Wang Y, Goodrich JM, Gillespie B, et al. An investigation of modifying effects of metallothionein single-nucleotide polymorphisms on the association between mercury exposure and biomarker levels. Environ Health Perspect. 2012;120(4):530–4.
40. Barcelos GR, Grotto D, de Marco KC, et al. Polymorphisms in glutathione-related genes modify mercury concentrations and antioxidant status in subjects environmentally exposed to methylmercury. Sci Total Environ. 2013;463–464:319–25. This study reports the influence of GSH related genes polymorphism on MeHg in a population with high exposure from fish intake.
41. de Oliveira AA, de Souza MF, Lengert A, et al. Genetic polymorphisms in glutathione (GSH-) related genes affect the plasmatic Hg/whole blood Hg partitioning and the distribution between inorganic and methylmercury levels in plasma collected from a fish-eating population. Biomed Res Int. 2014;2014:940952.
42. Julvez J, Smith GD, Golding J, et al. Prenatal methylmercury exposure and genetic predisposition to cognitive deficit at age 8 years. Epidemiology. 2013;24(5):643–50. This study provides evidence about the effect of gene-MeHg interactions on children neurodevelopment in a large birth cohort study.
43. Ng S, Lin CC, Hwang YH, et al. Mercury, APOE, and children's neurodevelopment. Neurotoxicology. 2013;37:85–92.
44. Ng S, Lin CC, Jeng SF, et al. Mercury, APOE, and child behavior. Chemosphere. 2014;120C:123–30.
45. Woods JS, Heyer NJ, Russo JE, et al. Genetic polymorphisms affecting susceptibility to mercury neurotoxicity in children: Summary findings from the Casa Pia Children's Amalgam Clinical Trial. Neurotoxicology. 2014;44:288–302.
46. Echeverria D, Woods JS, Heyer NJ, et al. Chronic low-level mercury exposure, BDNF polymorphism, and associations with cognitive and motor function. Neurotoxicol Teratol. 2005;27(6):781–96.
47. Echeverria D, Woods JS, Heyer NJ, et al. The association between a genetic polymorphism of coproporphyrinogen oxidase, dental mercury exposure and neurobehavioral response in humans. Neurotoxicol Teratol. 2006;28(1):39–48.
48. Echeverria D, Woods JS, Heyer NJ, et al. The association between serotonin transporter gene promotor polymorphism (5-HTTLPR) and elemental mercury exposure on mood and behavior in humans. J Toxicol Environ Health A. 2010;73(15):1003–20.
49. Heyer NJ, Echeverria D, Bittner Jr AC, et al. Chronic low-level mercury exposure, BDNF polymorphism, and associations with self-reported symptoms and mood. Toxicol Sci. 2004;81(2):354–63.
50. Heyer NJ, Echeverria D, Martin MD, et al. Catechol O-methyltransferase (COMT) VAL158MET functional polymorphism, dental mercury exposure, and self-reported symptoms and mood. J Toxicol Environ Health A. 2009;72(9):599–609.
51. Prince L, Korbas M, Davidson P, et al. Target organ specific activity of drosophila MRP (ABCC1) moderates developmental toxicity of methylmercury. Toxicol Sci. 2014;140(2):425–35.
52. Siest G, Pillot T, Regis-Bailly A, et al. Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin Chem. 1995;41(8 Pt 1):1068–86.
53. Hariri AR, Goldberg TE, Mattay VS, et al. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci. 2003;23(17):6690–4.